Einav Safyon

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities

A. Porgador, C. Cohen, Miryam Horovitz-Fried, 2014, Oncotarget.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Discovery of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIG, for the treatment of cancer.

O. Levy, L. Dassa, E. Ophir, 2017 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .